Differences in platelet function in patients with acute myeloid leukemia and myelodysplasia compared to equally thrombocytopenic patients with immune thrombocytopeniaBethan Psaila, Alan D. Michelson, James B. Bussel et al.|Journal of Thrombosis and Haemostasis|2011Cited by 131
The active metabolite of prasugrel inhibits ADP-stimulated thrombo-inflammatory markers of platelet activation: Influence of other blood cells, calcium, and aspirinJoseph A. Jakubowski, Andrew L. Frelinger, Marsha L. Fox et al.|Thrombosis and Haemostasis|2007Cited by 48
The active metabolite of prasugrel inhibits adenosine diphosphate- and collagen-stimulated platelet procoagulant activitiesAndrew L. Frelinger, Alan D. Michelson, Joseph A. Jakubowski et al.|Journal of Thrombosis and Haemostasis|2008Cited by 36
The active metabolite of prasugrel inhibits adenosine diphosphate- and collagen-stimulated platelet procoagulant activitiesAndrew L. Frelinger, Alan D. Michelson, Joseph A. Jakubowski et al.|Journal of Thrombosis and Haemostasis|2008Cited by 6
Abstract 3293: The Active Metabolite of Prasugrel Inhibits Platelet Procoagulant ActivitiesAndrew L. Frelinger, Alan D. Michelson, Joseph A. Jakubowski et al.|Circulation|2006Cited by 0